Hematologic parameter improvement

"Hematologic parameter improvement" refers to the clinical or laboratory observation denoting enhanced values in blood test results, such as increased hemoglobin concentration, normalized white cell or platelet counts, or improved red cell indices. These improvements are outcomes frequently measured to assess the effect of treatments in a variety of conditions, including anemia, infection, sepsis, and blood cancers. The term does not designate a molecular entity, protein, receptor, or classical therapeutic target, but is instead a summary descriptor of positive change in measurable hematological test results[2][3][5][6]. This designation should not be used as a target for drug discovery or mechanistic pharmacology, but rather as an efficacy endpoint or clinical effect.

Other names

Improvement of hematologic parametersHematologic parameter normalizationImproved hematological indices